$POAI
Predictive Oncology Inc.

2020 Q4 Form 10-K Financial Statement

#000117184321001786 Filed on March 15, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2019 Q4 2019
Revenue $290.0K $350.0K $1.412M
YoY Change -17.14% 12.9% -0.01%
Cost Of Revenue $90.00K $130.0K $531.8K
YoY Change -30.77% 18.18% 27.91%
Gross Profit $200.0K $220.0K $879.8K
YoY Change -9.09% 4.76% -11.66%
Gross Profit Margin 68.97% 62.86% 62.32%
Selling, General & Admin $2.150M $2.590M $11.69M
YoY Change -16.99% 1.17% 67.15%
% of Gross Profit 1075.0% 1177.27% 1329.25%
Research & Development $423.0K
YoY Change -19.63%
% of Gross Profit 48.08%
Depreciation & Amortization $300.0K $220.0K $704.9K
YoY Change 36.36% 450.0% 377.47%
% of Gross Profit 150.0% 100.0% 80.12%
Operating Expenses $2.860M $3.110M $12.12M
YoY Change -8.04% 2.64% 54.13%
Operating Profit -$2.660M -$2.890M -$22.64M
YoY Change -7.96% 2.48% 188.05%
Interest Expense $460.0K $0.00 $5.720M
YoY Change -100.0% -349.78%
% of Operating Profit
Other Income/Expense, Net $2.310M -$1.790M -$1.890M
YoY Change -229.05% -2657.14% -2800.0%
Pretax Income -$11.47M -$13.55M -$19.39M
YoY Change -15.35% 292.75% 92.17%
Income Tax
% Of Pretax Income
Net Earnings -$11.47M -$13.55M -$19.39M
YoY Change -15.35% 292.75% 92.25%
Net Earnings / Revenue -3955.17% -3871.43% -1373.71%
Basic Earnings Per Share
Diluted Earnings Per Share -$637.6K -$3.623M -$6.756M
COMMON SHARES
Basic Shares Outstanding 3.888M 2.870M
Diluted Shares Outstanding 2.870M

Balance Sheet

Concept 2020 Q4 2019 Q4 2019
SHORT-TERM ASSETS
Cash & Short-Term Investments $680.0K $150.0K $150.0K
YoY Change 353.33% -6.25% -6.25%
Cash & Equivalents $678.3K $150.8K
Short-Term Investments
Other Short-Term Assets $290.0K $160.0K $160.0K
YoY Change 81.25% -50.0% -50.0%
Inventory $289.5K $190.2K $190.0K
Prepaid Expenses
Receivables $256.9K $297.1K $300.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.514M $798.3K $800.0K
YoY Change 89.69% -45.01% -44.83%
LONG-TERM ASSETS
Property, Plant & Equipment $3.823M $1.508M $2.240M
YoY Change 153.53% 735.56% 1144.44%
Goodwill $2.814M $15.69M
YoY Change -82.07%
Intangibles $3.398M $3.649M
YoY Change -6.89% 278.38%
Long-Term Investments
YoY Change
Other Assets $116.3K
YoY Change
Total Long-Term Assets $11.55M $21.58M $21.58M
YoY Change -46.49% 855.81% 854.87%
TOTAL ASSETS
Total Short-Term Assets $1.514M $798.3K $800.0K
Total Long-Term Assets $11.55M $21.58M $21.58M
Total Assets $13.06M $22.38M $22.38M
YoY Change -41.63% 503.28% 503.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.372M $3.156M $3.160M
YoY Change -56.52% 608.04% 602.22%
Accrued Expenses $2.588M $2.372M $2.830M
YoY Change 9.13% 85.41% 121.09%
Deferred Revenue $53.03K $40.38K
YoY Change 31.31% 75.09%
Short-Term Debt $0.00 $4.796M $4.800M
YoY Change -100.0% 193.34% 194.48%
Long-Term Debt Due $4.430M $6.214M
YoY Change -28.7%
Total Short-Term Liabilities $9.337M $10.87M $10.87M
YoY Change -14.13% 197.47% 196.99%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $235.7K $270.0K
YoY Change
Total Long-Term Liabilities $235.7K $0.00 $270.0K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $9.337M $10.87M $10.87M
Total Long-Term Liabilities $235.7K $0.00 $270.0K
Total Liabilities $10.42M $11.14M $11.14M
YoY Change -6.52% 204.86% 204.37%
SHAREHOLDERS EQUITY
Retained Earnings -$108.4M -$82.50M
YoY Change 31.38% 30.73%
Common Stock $198.0K $40.57K
YoY Change 388.2% 187.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.643M $11.23M $11.23M
YoY Change
Total Liabilities & Shareholders Equity $13.06M $22.38M $22.38M
YoY Change -41.63% 503.28% 503.23%

Cashflow Statement

Concept 2020 Q4 2019 Q4 2019
OPERATING ACTIVITIES
Net Income -$11.47M -$13.55M -$19.39M
YoY Change -15.35% 292.75% 92.25%
Depreciation, Depletion And Amortization $300.0K $220.0K $704.9K
YoY Change 36.36% 450.0% 377.47%
Cash From Operating Activities -$2.310M -$2.790M -$8.732M
YoY Change -17.2% 128.69% 65.14%
INVESTING ACTIVITIES
Capital Expenditures -$200.0K -$10.00K $5.888K
YoY Change 1900.0% 0.0% -96.69%
Acquisitions
YoY Change
Other Investing Activities $60.00K $0.00 -$570.0K
YoY Change -100.0% -35.23%
Cash From Investing Activities -$140.0K -$10.00K -$599.1K
YoY Change 1300.0% -99.01% -46.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $5.323M
YoY Change 79.86%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 650.0K 2.850M 9.320M
YoY Change -77.19% 30.73% 60.84%
NET CHANGE
Cash From Operating Activities -2.310M -2.790M -8.732M
Cash From Investing Activities -140.0K -10.00K -599.1K
Cash From Financing Activities 650.0K 2.850M 9.320M
Net Change In Cash -1.800M 50.00K -11.32K
YoY Change -3700.0% -200.0% -98.13%
FREE CASH FLOW
Cash From Operating Activities -$2.310M -$2.790M -$8.732M
Capital Expenditures -$200.0K -$10.00K $5.888K
Free Cash Flow -$2.110M -$2.780M -$8.738M
YoY Change -24.1% 129.75% 59.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 poai Debt Extinguishment Costs
DebtExtinguishmentCosts
1996681
CY2019 poai Debt Extinguishment Costs
DebtExtinguishmentCosts
581073
CY2020 poai Debt Modification Costs
DebtModificationCosts
CY2019 poai Debt Modification Costs
DebtModificationCosts
162750
CY2020Q4 poai Deferred Tax Assets Liabilities Gross
DeferredTaxAssetsLiabilitiesGross
82105085
CY2019Q4 poai Deferred Tax Assets Liabilities Gross
DeferredTaxAssetsLiabilitiesGross
80642401
CY2020 dei Trading Symbol
TradingSymbol
poai
CY2020Q4 poai Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
2588047
CY2019Q4 poai Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
2371633
CY2019 poai Adjustments To Derivative Liability For Warrants Issued
AdjustmentsToDerivativeLiabilityForWarrantsIssued
-47078
CY2020Q4 poai Class Of Warrant Or Right Number Of Warrants Vested And Exercisable
ClassOfWarrantOrRightNumberOfWarrantsVestedAndExercisable
7353376
CY2019Q4 poai Class Of Warrant Or Right Number Of Warrants Vested And Exercisable
ClassOfWarrantOrRightNumberOfWarrantsVestedAndExercisable
2171610
CY2020 poai Consideration For Extinguishment Of Debt
ConsiderationForExtinguishmentOfDebt
CY2019 poai Consideration For Extinguishment Of Debt
ConsiderationForExtinguishmentOfDebt
26711790
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0001446159
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48794320
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q2 dei Entity Public Float
EntityPublicFloat
32138990
CY2020 dei Entity Registrant Name
EntityRegistrantName
Predictive Oncology Inc.
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2020Q4 poai Deferred Tax Assets Nqso Compensation
DeferredTaxAssetsNQSOCompensation
1738217
CY2019Q4 poai Deferred Tax Assets Nqso Compensation
DeferredTaxAssetsNQSOCompensation
1589430
CY2020Q4 poai Deferred Tax Assets Operating Loss Carryforwards And Credits
DeferredTaxAssetsOperatingLossCarryforwardsAndCredits
80038356
CY2019Q4 poai Deferred Tax Assets Operating Loss Carryforwards And Credits
DeferredTaxAssetsOperatingLossCarryforwardsAndCredits
78417618
CY2020Q4 poai Deferred Tax Assets Right Of Use Assets
DeferredTaxAssetsRightOfUseAssets
13861
CY2019Q4 poai Deferred Tax Assets Right Of Use Assets
DeferredTaxAssetsRightOfUseAssets
CY2020Q4 poai Deferred Tax Liabilities Original Issue Discount
DeferredTaxLiabilitiesOriginalIssueDiscount
CY2019Q4 poai Deferred Tax Liabilities Original Issue Discount
DeferredTaxLiabilitiesOriginalIssueDiscount
14021
CY2020 poai Defined Contribution Plan Employer Contribution Amount
DefinedContributionPlanEmployerContributionAmount
119555
CY2019 poai Defined Contribution Plan Employer Contribution Amount
DefinedContributionPlanEmployerContributionAmount
110714
CY2019 poai Derivative Liability Write Off
DerivativeLiabilityWriteOff
22644
CY2020 poai Derivatives Debt Issued
DerivativesDebtIssued
636563
CY2019 poai Derivatives Debt Issued
DerivativesDebtIssued
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1765907
CY2020 poai Effective Income Tax Rate Reconciliation Acquisition Adjustment Amount
EffectiveIncomeTaxRateReconciliationAcquisitionAdjustmentAmount
CY2019 poai Effective Income Tax Rate Reconciliation Acquisition Adjustment Amount
EffectiveIncomeTaxRateReconciliationAcquisitionAdjustmentAmount
-66394188
CY2020 poai Effective Income Tax Rate Reconciliation Foreign Income Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxBenefitAmount
62146
CY2019 poai Effective Income Tax Rate Reconciliation Foreign Income Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxBenefitAmount
104050
CY2020 poai Effective Income Tax Rate Reconciliation Oid And Derivatives Amount
EffectiveIncomeTaxRateReconciliationOIDAndDerivativesAmount
CY2019 poai Effective Income Tax Rate Reconciliation Oid And Derivatives Amount
EffectiveIncomeTaxRateReconciliationOIDAndDerivativesAmount
-141908
CY2020 poai Effective Income Tax Rate Reconciliation State Net Operating Loss Adjustment Amount
EffectiveIncomeTaxRateReconciliationStateNetOperatingLossAdjustmentAmount
-1141662
CY2019 poai Effective Income Tax Rate Reconciliation State Net Operating Loss Adjustment Amount
EffectiveIncomeTaxRateReconciliationStateNetOperatingLossAdjustmentAmount
-1054778
CY2020 poai Effective Income Tax Rate Reconciliation State Tax Rate Adjustment Amount
EffectiveIncomeTaxRateReconciliationStateTaxRateAdjustmentAmount
-65112
CY2019 poai Effective Income Tax Rate Reconciliation State Tax Rate Adjustment Amount
EffectiveIncomeTaxRateReconciliationStateTaxRateAdjustmentAmount
17585
CY2020 poai Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity On Exercise
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquityOnExercise
1701756
CY2020 poai Equity Instruments Issued For Management And Consulting
EquityInstrumentsIssuedForManagementAndConsulting
450901
CY2019 poai Equity Instruments Issued For Management And Consulting
EquityInstrumentsIssuedForManagementAndConsulting
484923
CY2020 poai Fixed Assets Acquired For Financing Arrangements
FixedAssetsAcquiredForFinancingArrangements
113192
CY2019 poai Fixed Assets Acquired For Financing Arrangements
FixedAssetsAcquiredForFinancingArrangements
CY2020 poai Fixed Assets Acquired For Notes Receivable And Common Stock
FixedAssetsAcquiredForNotesReceivableAndCommonStock
2962767
CY2019 poai Fixed Assets Acquired For Notes Receivable And Common Stock
FixedAssetsAcquiredForNotesReceivableAndCommonStock
CY2020 poai Forebearanace Settlement On Bridge Loan
ForebearanaceSettlementOnBridgeLoan
CY2019 poai Forebearanace Settlement On Bridge Loan
ForebearanaceSettlementOnBridgeLoan
503009
CY2020 poai Gain Loss On Note Receivable Asset Purchase Agreement
GainLossOnNoteReceivableAssetPurchaseAgreement
1290000
CY2019 poai Gain Loss On Note Receivable Asset Purchase Agreement
GainLossOnNoteReceivableAssetPurchaseAgreement
CY2020 poai Gain Loss On Receivable Previously Considered Uncollectable
GainLossOnReceivablePreviouslyConsideredUncollectable
1290000
CY2019 poai Gain Loss On Receivable Previously Considered Uncollectable
GainLossOnReceivablePreviouslyConsideredUncollectable
CY2020 poai Gain Loss On Revaluation Of Equity Method Investment
GainLossOnRevaluationOfEquityMethodInvestment
CY2019 poai Gain Loss On Revaluation Of Equity Method Investment
GainLossOnRevaluationOfEquityMethodInvestment
6164260
CY2020 poai Gain Losses On Debt Revaluation
GainLossesOnDebtRevaluation
CY2019 poai Gain Losses On Debt Revaluation
GainLossesOnDebtRevaluation
1222244
CY2020 poai Increase In Operating Lease Right Of Asset And Lease Liability Due To Lease Modification
IncreaseInOperatingLeaseRightOfAssetAndLeaseLiabilityDueToLeaseModification
1417077
CY2019 poai Increase In Operating Lease Right Of Asset And Lease Liability Due To Lease Modification
IncreaseInOperatingLeaseRightOfAssetAndLeaseLiabilityDueToLeaseModification
CY2020 poai Issuance Of Shares And Prefunded Warrants Pursuant To Private Placement Value
IssuanceOfSharesAndPrefundedWarrantsPursuantToPrivatePlacementValue
457823
CY2020 poai Payments For Penalties
PaymentsForPenalties
247327
CY2019 poai Payments For Penalties
PaymentsForPenalties
202294
CY2020 poai Proceeds From Issuance Of Stock Pursuant To Equity Line
ProceedsFromIssuanceOfStockPursuantToEquityLine
4891348
CY2019 poai Proceeds From Issuance Of Stock Pursuant To Equity Line
ProceedsFromIssuanceOfStockPursuantToEquityLine
319196
CY2020 poai Stock Issued During Period Shares Exchange Agreement
StockIssuedDuringPeriodSharesExchangeAgreement
2322878
CY2019 poai Stock Issued During Period Shares Exchange Agreement
StockIssuedDuringPeriodSharesExchangeAgreement
CY2019 poai Stock Issued During Period Value Convertible Preferred Shares Issued
StockIssuedDuringPeriodValueConvertiblePreferredSharesIssued
2338840
CY2019 poai Stock Issued During Period Value Extinguishment Of Debt
StockIssuedDuringPeriodValueExtinguishmentOfDebt
6463309
CY2019 poai Stock Issued During Period Value Forebearance For Bridge Loan
StockIssuedDuringPeriodValueForebearanceForBridgeLoan
158349
CY2020 poai Stock Issued During Period Value Inducement To Convertible Debt
StockIssuedDuringPeriodValueInducementToConvertibleDebt
120000
CY2019 poai Stock Issued During Period Value Inducement To Equity Line
StockIssuedDuringPeriodValueInducementToEquityLine
450000
CY2020 poai Stock Issued During Period Value Inducement To Equity Line
StockIssuedDuringPeriodValueInducementToEquityLine
4891348
CY2020 poai Stock Issued During Period Value Inducement To Promissory Note Extension
StockIssuedDuringPeriodValueInducementToPromissoryNoteExtension
41250
CY2019 poai Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
5970
CY2020 poai Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
192150
CY2020Q4 poai Valuation Allowance Percentage
ValuationAllowancePercentage
1
CY2020Q4 us-gaap Assets
Assets
13060436
CY2019Q4 us-gaap Assets
Assets
22375510
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1246541
CY2019 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2023315
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
313709
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
290552
CY2020 poai Warrants Issued
WarrantsIssued
CY2019 poai Warrants Issued
WarrantsIssued
47078
CY2020 poai Warrants Issued Debt Issuance
WarrantsIssuedDebtIssuance
179324
CY2019 poai Warrants Issued Debt Issuance
WarrantsIssuedDebtIssuance
180640
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1372070
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3155641
CY2020Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
256878
CY2019Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
297055
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
256878
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
297055
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1331847
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
771574
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
110826949
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
93653667
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2250422
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
721269
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
780269
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2250422
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1514235
CY2019Q4 us-gaap Assets Current
AssetsCurrent
798264
CY2019 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-20947033
CY2019 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1457625
CY2020 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
CY2019 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
248102
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
678332
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
150831
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
150831
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
162152
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
678332
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
527501
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11321
CY2020Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
238504
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
7353376
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
24000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19804787
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4056652
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
198048
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
40567
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">Credit Risk </div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0"></div> <div style=" font-size: 10pt; margin: 0pt 0">Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high credit quality financial institutions and, by policy, generally limits the amount of credit exposure to any <div style="display: inline; font-style: italic; font: inherit;">one</div> financial institution. The Company has a credit risk of <div style="display: inline; font-style: italic; font: inherit;">$238,504</div> for cash amounts held in a single institution that are in excess of amounts issued by the Federal Deposit Insurance Corporation.</div></div></div></div>
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
53028
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
40384
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
53028
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
40384
CY2020 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
35000
CY2019 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
447192
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
531810
CY2020 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
267328
CY2019 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
378873
CY2020Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
4676755
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
82105085
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
80642401
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
295775
CY2019Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
389689
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2020 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2019 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
CY2018 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
CY2019 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.04
CY2018 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.04
CY2020 us-gaap Depreciation
Depreciation
711139
CY2019 us-gaap Depreciation
Depreciation
414331
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1024848
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
704883
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1024848
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
704883
CY2019Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
5146226
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
244830
CY2019Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
350426
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
244830
CY2019Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
350426
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
295775
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
403710
CY2020Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
4331
CY2019Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
3740
CY2020Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
11641
CY2019Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
7480
CY2020Q4 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
63145
CY2019Q4 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
10708
CY2020Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
297639
CY2019Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
295941
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
82400860
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
81046111
CY2020Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
7196
CY2019Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
6891
CY2020Q4 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
CY2019Q4 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
657633
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2020Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
CY2019Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
63846
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
56670
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
162628
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
0
CY2020Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
294382
CY2019Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
50989
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
2.21
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
6.86
CY2020 us-gaap Earnings Per Share Basic Distributed
EarningsPerShareBasicDistributed
2.21
CY2019 us-gaap Earnings Per Share Basic Distributed
EarningsPerShareBasicDistributed
6.86
CY2018Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
272745
CY2019Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
50989
CY2020Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
294382
CY2020 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
50989
CY2019 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
221757
CY2020 us-gaap Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity
EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity
2669408
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
6390
CY2019 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-221756
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
221756
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
1765906
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
69722
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
728320
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
414611
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
2298995
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
331071
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
182738
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
182738
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
182738
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
219821
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3398101
CY2020 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1765907
CY2019 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
221756
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-5434463
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3977561
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
268968
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-1183535
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
2762014
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
1701000
CY2019 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
23790290
CY2020 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
12876498
CY2019 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
8870250
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
461020
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-115896
CY2020 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-120577
CY2019 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1096
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1996681
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-513250
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10351973
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9781218
CY2018Q4 us-gaap Goodwill
Goodwill
CY2019Q4 us-gaap Goodwill
Goodwill
15690290
CY2020Q4 us-gaap Goodwill
Goodwill
2813792
CY2020Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
20976498
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
12876498
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
8100000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
2997000
CY2020Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
9879458
CY2020 us-gaap Gross Profit
GrossProfit
805080
CY2019 us-gaap Gross Profit
GrossProfit
879755
CY2020 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2019 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
770250
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-439637
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1462683
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
69489684
CY2020 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
44120
CY2019 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
73869
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-143316
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
700966
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1285678
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-578746
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-368635
CY2020 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
CY2019 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
51143
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1656158
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
365772
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-69913
CY2019Q4 us-gaap Liabilities
Liabilities
11144192
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
12644
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
17319
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
94715
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-91114
CY2020 us-gaap Increase Decrease In Notes Receivable Current
IncreaseDecreaseInNotesReceivableCurrent
CY2019 us-gaap Increase Decrease In Notes Receivable Current
IncreaseDecreaseInNotesReceivableCurrent
975000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
245526
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
29747
CY2020Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
4126421
CY2019Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
4064023
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3398101
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3649412
CY2020 us-gaap Interest Paid Net
InterestPaidNet
145831
CY2019 us-gaap Interest Paid Net
InterestPaidNet
146064
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
95898
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
91410
CY2020Q4 us-gaap Inventory Net
InventoryNet
289535
CY2019Q4 us-gaap Inventory Net
InventoryNet
190156
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
151366
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
69821
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
42271
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
28925
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1706009
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
689368
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
48552
CY2020Q4 us-gaap Liabilities
Liabilities
10417755
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
71420
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
170910
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
725759
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
263411
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13060436
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22375510
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9336921
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10873928
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12952689
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9320217
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-167456
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-599087
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12257732
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8732451
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-25884397
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-19390766
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-26438684
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19680701
CY2020Q4 us-gaap Notes Payable
NotesPayable
4431925
CY2019Q4 us-gaap Notes Payable
NotesPayable
4795800
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
4431925
CY2019Q4 us-gaap Notes Payable Current
NotesPayableCurrent
4795800
CY2020 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2020 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2351709
CY2019 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2960131
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-25360037
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-22644743
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
565581
CY2019 us-gaap Operating Lease Expense
OperatingLeaseExpense
431170
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1442598
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
597469
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
459481
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
845129
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
270264
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1395351
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
729745
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y120D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y102D
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
116257
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
235705
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
CY2020 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
2427026
CY2019 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
3466696
CY2020 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
843440
CY2019 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
65300
CY2020 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
62398
CY2019 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
20719
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
298379
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5888
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
53472
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
289490
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
160222
CY2020 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">Reclassifications</div></div> <div style=" font-size: 10pt; margin: 0pt 0"></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0">Certain reclassifications have been made to the prior years' financial statements to conform to the current year presentation. The reclassifications had <div style="display: inline; font-style: italic; font: inherit;">no</div> effect on previously reported results of operations, cash flows or stockholders' equity.</div></div></div></div>
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5057919
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5323018
CY2020 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
CY2019 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
2338840
CY2020 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
2761867
CY2019 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
2690000
CY2020 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
25416
CY2019 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
CY2020 us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
CY2019 us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
154418
CY2020 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
193321
CY2019 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1935855
CY2019 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
5970
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5154547
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2279373
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3822700
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1507799
CY2020 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
CY2019 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
1037524
CY2020 us-gaap Repayments Of Debt
RepaymentsOfDebt
1472389
CY2019 us-gaap Repayments Of Debt
RepaymentsOfDebt
1154513
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
372710
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
422964
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-108383108
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82498711
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1252272
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1411565
CY2020 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
554287
CY2019 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
289935
CY2019 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
5612250
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1028354
CY2019 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
34923
CY2020 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
430206
CY2020 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
2322878
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2642681
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
11231318
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
584937
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1912899
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
721269
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
2250422
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1013547
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
977420
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
669050
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
5.29
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
11.93
CY2020Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1013547
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y277D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y138D
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline; font-weight: bold;">Accounting Policies and Estimates</div></div> <div style=" font-size: 10pt; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; margin: 0pt 0">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and disclosure of contingent assets and liabilities at the date of the financial statements and during the reporting period. Actual results could materially differ from those estimates.</div></div></div></div>
CY2020 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2019 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11950154
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2870132
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11950154
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2870132
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11950154
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2870132

Files In Submission

Name View Source Status
0001171843-21-001786-index-headers.html Edgar Link pending
0001171843-21-001786-index.html Edgar Link pending
0001171843-21-001786.txt Edgar Link pending
0001171843-21-001786-xbrl.zip Edgar Link pending
exh_211.htm Edgar Link pending
exh_231.htm Edgar Link pending
exh_232.htm Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
exh_429.htm Edgar Link pending
f10k_031521p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
poai-20201231.xml Edgar Link completed
poai-20201231.xsd Edgar Link pending
poai-20201231_cal.xml Edgar Link unprocessable
poai-20201231_def.xml Edgar Link unprocessable
poai-20201231_lab.xml Edgar Link unprocessable
poai-20201231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending